A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder
Craig Jaffe1, Kristen R Bush, Kristy Straits-Troster
1Department of Psychiatry and Behavioral Sciences, University of Washington, 12013 Pinehurst Way NE, Seattle, WA 98125, USA. cjaffe@u.washington.edu
Insights
Methamphetamine-dependent patients with childhood attention deficit hyperactivity disorder (ADHD) symptoms reported more frequent drug use and worse psychiatric symptoms. While abstinence improved cognition for most, those with ADHD did not improve attention skills.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Psychology
Background:
- Childhood attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder.
- Methamphetamine dependence is a significant public health concern.
- Comorbidity between ADHD and substance use disorders is well-documented.
Purpose of the Study:
- To investigate the prevalence of childhood ADHD in methamphetamine-dependent inpatients.
- To examine the impact of ADHD on psychiatric symptomatology and cognitive functioning.
- To assess the effects of abstinence on cognitive and psychiatric outcomes in this population.
Main Methods:
- Fifty-one methamphetamine-dependent inpatients were screened for ADHD using the Wender Utah Rating Scale.
- Baseline assessments included neuropsychological tests and the Brief Symptom Inventory (BSI).
- Cognitive and psychiatric assessments were repeated at three-week follow-up.
Main Results:
- 70.6% of participants screened positive for ADHD, reporting higher methamphetamine use.
- ADHD group showed similar baseline cognitive function but worse psychiatric symptoms.
- With abstinence, all improved in most cognitive domains (except memory) and psychiatric symptoms, but the ADHD group did not improve attention.
Conclusions:
- Childhood ADHD symptoms are prevalent in methamphetamine-dependent individuals.
- ADHD complicates treatment and is associated with poorer psychiatric outcomes.
- Targeted interventions for ADHD may be necessary for improved treatment outcomes in this population.
Abstract:
Methamphetamine-dependent inpatients (N = 51) were screened for childhood attention deficit hyperactivity disorder (ADHD) using the Wender Utah Rating Scale upon admission to 30-day inpatient treatment. Baseline assessments included neuropsychological tests of executive function, memory, information processing, verbal fluency, attention, motor skills, and the Brief Symptom Inventory (BSI), a measure of psychiatric symptomatology. The thirty-six participants (70.6%) screening positive for ADHD reported significantly more frequent methamphetamine use prior to baseline. Baseline cognitive functioning was similar between groups, but the presumptive ADHD participants exhibited significantly worse psychiatric symptomatology. At three-week follow- up, 41 participants (80.4%) repeated the neuropsychological battery and BSI. All 10 non-completers screened positive for ADHD. The entire sample improved with abstinence in most neuropsychological domains except memory. The presumptive ADHD group failed to improve on tests of attention. All participants demonstrated significant reductions in psychiatric symptoms with abstinence. Methamphetamine-dependent individuals with ADHD symptoms are common and pose a significant treatment challenge.
More Related Videos
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug Abuse and Addiction: Pharmacological Phenomena


